Alzex Neuropharma Inc. TRRI
Set alert
0.00 USD 0.00 0.00%
At close · Oct 30
0.0003 Day range 0.0003
0.0001 52-week range 0.0012
- YTD
- +100.00%
- 1 year
- +33.33%
- Open
- 0.0003
- Prev close
- 0.0004
- Mkt cap
- 602
- Vol
- 3.68K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.0003
- High
- 0.0003
Financial health
Altman Z-Score
-496.14 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -2.0×
FY 2008 5y median -2.0× FY 2022
P/S 0.0×
FY 2008 5y median 0.0× FY 2022
P/B -1.5×
FY 2008 5y median -1.5× FY 2022
P/FCF -3.8×
FY 2008 5y median 14.9× FY 2022
EV/EBITDA -2.6×
FY 2008 5y median 0.5× FY 2022
EV/Sales 0.0×
FY 2008 5y median 0.0× FY 2022
FCF Yield -26.6%
FY 2008 5y median 0.0% FY 2022
Profitability
Gross Margin 0.0%
FY 2008 5y median 0.0% FY 2022
Operating Margin 0.0%
FY 2008 5y median 0.0% FY 2022
Net Margin 0.0%
FY 2008 5y median 0.0% FY 2022
ROE 76.0%
FY 2008 5y median 6.6% FY 2022
ROIC 128.9%
FY 2008 5y median 44.1% FY 2022
ROA -844.7%
FY 2008 5y median -117.4% FY 2022
Growth (YoY)
Revenue 0.0%
FY 2008 FY 2022
Operating Income -604.4%
FY 2008 FY 2022
EPS (diluted) -853.4%
FY 2008 FY 2022
Free Cash Flow -294.4%
FY 2008 FY 2022
Financial Health
Current Ratio 0.1×
FY 2008 5y median 0.0× FY 2022
Quick Ratio 0.1×
FY 2008 5y median 0.0× FY 2022
Debt / Equity -0.4×
FY 2008 5y median -0.4× FY 2022
Net Debt / EBITDA -0.6×
FY 2008 5y median -0.0× FY 2022
Interest Coverage -74.2×
FY 2008 5y median 0.0× FY 2022
Dividends
Dividend Yield 0.0%
FY 2008 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2008 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-12-31